Data compiled by Redley Lamar · ChainSifter Intelligence
8Suppliers
6Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Wave Life Sciences Ltd. (WVE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
18Total relationships
3Distinct source URLs
7High confidence
0.782Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Wave Life Sciences Ltd. Suppliers
Ticker
Name
Confidence
Evidence
GLAXOSMITHKLINE-INTELLECTUAL-PROPERTY-NO-3
GLAXOSMITHKLINE-INTELLECTUAL-PROPERTY-NO-3
90%
Pursuant to the GSK Collaboration Agreement, we and GSK have agreed to collaborate on the research, development, and commercialization of oligonucleotide therapeutics.
GLAXO-GROUP-LIMITED
GLAXO-GROUP-LIMITED
85%
With respect to the $50.0 million equity investment, on December 13, 2022, we entered into a Share Purchase Agreement (the "GSK Share Purchase Agreement") with Glaxo Group Limited ("GGL"), an affilia…
SHIN-NIPPON-BIOMEDICAL-LABORATORIES-LTD
SHIN-NIPPON-BIOMEDICAL-LABORATORIES-LTD
80%
Pursuant to the terms of various contract research service agreements with SNBL, a contract research organization and one of our shareholders, and its affiliates, we paid SNBL $4.0 million from Janua…
Reciprocal relationship from DYN graph: ces and our business and operations, including clinical trials, could be disrupted by any problems with our significant third-party vendors. We engage a number…
GLAXF
GSK plc
72%
Reciprocal relationship from GLAXF graph: Reciprocal relationship from WVE graph: Reciprocal relationship from GLAXF graph: Reciprocal relationship from WVE graph: Reciprocal relationship from GLAXF …
Reciprocal relationship from IBIO graph: Reciprocal relationship from WVE graph: Reciprocal relationship from IBIO graph: Reciprocal relationship from WVE graph: Reciprocal relationship from IBIO gra…
Reciprocal relationship from MREO graph: Reciprocal relationship from WVE graph: Reciprocal relationship from MREO graph: Reciprocal relationship from WVE graph: Reciprocal relationship from MREO gra…
Reciprocal relationship from TRDA graph: Reciprocal relationship from WVE graph: Reciprocal relationship from TRDA graph: Reciprocal relationship from WVE graph: Reciprocal relationship from TRDA gra…
Reciprocal relationship from DYN graph: Reciprocal relationship from WVE graph: Reciprocal relationship from DYN graph: Reciprocal relationship from WVE graph: Reciprocal relationship from DYN graph:…
Reciprocal relationship from MREO graph: Reciprocal relationship from WVE graph: Reciprocal relationship from MREO graph: Reciprocal relationship from WVE graph: Reciprocal relationship from MREO gra…
TKPHF
Takeda Pharmaceutical Company Limited
72%
hich would increase the number of programs available to both parties. The Company will lead all preclinical research for GSK and the Company’s collaboration programs up to investigational new drug (“…
TKPHF
Takeda Pharmaceutical Company Limited
72%
Reciprocal relationship from TKPHF graph: Reciprocal relationship from WVE graph: hich would increase the number of programs available to both parties. The Company will lead all preclinical research …
Reciprocal relationship from TRDA graph: everal risks, including disruptions in supply, price increases or late deliveries. There are, in general, relatively few alternative sources of supply for sub…
Wave Life Sciences Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
WVE-DEBT
Debt stack $15.7M
90%
Market cache reports total debt of $15.7M.
WVE-DEBT-13626
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2015-12-31.
WVE-DEBT-13625
Warrants outstanding: 46938000
90%
xbrl warrant detail from xbrl 2025-12-31.
Wave Life Sciences Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Wave Life Sciences Ltd..
Wave Life Sciences Ltd. Ownership
Holder
Name
Confidence
Evidence
WVE-OWNER-RA-CAPITAL-MANAGEMENT-L-P
RA CAPITAL MANAGEMENT, L.P.
90%
13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 237 tracked holders.
Wave Life Sciences Ltd. Extended Supply Chain Network
